Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including ...

"It showed me what a disadvantage I was at compared to people who don’t have obsessive thoughts about food. It never had ...

Dieticians say that weight-loss drugs are leading to an increase in malnutrition and related conditions. Dieticians are ...

Weight loss medications are pushing consumers to become more intentional about what they eat. That has major implications for ...

For decades, restaurants have been able to react to diet trends with visible signals and callouts. Menus at Applebee’s ...

The Navitus survey also found that nearly 60% of users are aware of safety concerns tied to compounded GLP-1 products. More than 86% said they would be willing to pay more for an FDA-approved ...

GLP-1s are changing the menu landscape for restaurants as diners fundamentally change how they eat. Here's what you'll start ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

Medically reviewed by Erika Prouty, PharmD Key Takeaways GLP-1 medications already slow digestion and can cause stomach upset. If adding magnesium, start with a low dose and increase gradually to ...

Consumer health advertising is driving many employees to take action on GLP-1s. But without guidance, those decisions could be risky.

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular weight-loss drugs like Ozempic and Zepbound.